Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Dec 29;12(1):251.
doi: 10.3390/jcm12010251.

Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies

Woo Hyun Paik  1 , Kyong Joo Lee  2
Affiliations
Review

Management of Small Nonfunctioning Pancreatic Neuroendocrine Neoplasms: Current Opinion and Controversies

Woo Hyun Paik et al. J Clin Med. .

Abstract

The incidence of small and asymptomatic pancreatic neuroendocrine neoplasms (PNENs) has increased due to the widespread use of high-resolution diagnostic imaging in screening programs. Most PNENs are slow-growing indolent neoplasms. However, a local invasion or metastasis can sometimes occur with PNENs, leading to a poor prognosis. The management of small, nonfunctioning PNENs remains under debate. The National Comprehensive Cancer Network guidelines recommend observation in selected cases of small PNENs less than 2 cm. Pancreatic surgery remains a high-risk operation with a 28-30% morbidity and 1% mortality. Therefore, the decision on how to manage small PNENs is challenging. This review focuses on the management of small nonfunctioning PNENs. We also highlight the malignant potential of small PNENs according to tumor size, tumor grade, and tumor biomarker. Endoscopic-ultrasound-guided biopsy is recommended to evaluate the potential risk of malignancy. Furthermore, we discuss the current guidelines and future directions for the management of small PNENs.

Keywords: asymptomatic; nonfunctional; pancreatic neuroendocrine neoplasm; small.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Similar articles

See all similar articles

Cited by

References

    1. Franko J., Feng W., Yip L., Genovese E., Moser A.J. Non-functional neuroendocrine carcinoma of the pancreas: Incidence, tumor biology, and outcomes in 2158 patients. J. Gastrointest. Surg. 2010;14:541–548. doi: 10.1007/s11605-009-1115-0. - DOI - PubMed
    1. Khashab M.A., Yong E., Lennon A.M., Shin E.J., Amateau S., Hruban R.H., Olino K., Giday S., Fishman E.K., Wolfgang C.L., et al. EUS is still superior to multidetector computerized tomography for detection of pancreatic neuroendocrine tumors. Gastrointest. Endosc. 2011;73:691–696. doi: 10.1016/j.gie.2010.08.030. - DOI - PubMed
    1. Oberg K. Pancreatic endocrine tumors. Semin. Oncol. 2010;37:594–618. doi: 10.1053/j.seminoncol.2010.10.014. - DOI - PubMed
    1. Halfdanarson T.R., Rabe K.G., Rubin J., Petersen G.M. Pancreatic neuroendocrine tumors (PNETs): Incidence, prognosis and recent trend toward improved survival. Ann. Oncol. 2008;19:1727–1733. doi: 10.1093/annonc/mdn351. - DOI - PMC - PubMed
    1. Kloppel G., Rindi G., Perren A., Komminoth P., Klimstra D.S. The ENETS and AJCC/UICC TNM classifications of the neuroendocrine tumors of the gastrointestinal tract and the pancreas: A statement. Virchows Arch. 2010;456:595–597. doi: 10.1007/s00428-010-0924-6. - DOI - PubMed

LinkOut - more resources